Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Equity Ratio (2016 - 2025)

Marimed has reported Equity Ratio over the past 15 years, most recently at 0.25 for Q4 2025.

  • Quarterly Equity Ratio fell 12.72% to 0.25 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.25 through Dec 2025, down 12.72% year-over-year, with the annual reading at 0.25 for FY2025, 12.72% down from the prior year.
  • Equity Ratio was 0.25 for Q4 2025 at Marimed, down from 0.26 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.43 in Q2 2023 and troughed at 0.16 in Q1 2021.
  • The 5-year median for Equity Ratio is 0.32 (2022), against an average of 0.31.
  • Year-over-year, Equity Ratio surged 25693.97% in 2021 and then decreased 24.42% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.29 in 2021, then rose by 27.8% to 0.38 in 2022, then dropped by 6.72% to 0.35 in 2023, then dropped by 19.47% to 0.28 in 2024, then decreased by 12.72% to 0.25 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Equity Ratio are 0.25 (Q4 2025), 0.26 (Q3 2025), and 0.28 (Q2 2025).